SCHEMBL3144178

SCHEMBL3144178

CCOC(=O)C1(C)CC1(C)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.41
ALOX15 P16050 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
ALDH1A1 P00352 3/20 0.37
OPRM1 P35372 5/20 0.36
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HSD17B10 Q99714 1/20 0.36
ATM Q13315 1/20 0.35
OPRD1 P41143 3/20 0.35
OPRK1 P41145 3/20 0.35
SLC22A1 O15245 1/20 0.35
SLC6A4 P31645 1/20 0.35
ADRA1A P35348 1/20 0.35
KCNH2 Q12809 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10950638 0.80 POLB (0.44) POLBALOX15KDM4EMEN1MAPT
SCHEMBL30142954 0.80 SMN1; SMN2 (0.41) POLBALOX15KDM4EMEN1MAPT
SCHEMBL11019559 0.77 LMNA (0.51) POLBMEN1MAPTKMT2AALDH1A1
SCHEMBL9578027 0.77 POLB (0.42) POLBALOX15KDM4EMEN1MAPT
SCHEMBL5934973 0.77 CYP3A4 (0.44) POLBALOX15KDM4EMEN1MAPT
SCHEMBL19307390 0.76 FFAR3 (0.47) POLBMEN1KMT2AALDH1A1LMNA
SCHEMBL301061 0.76 FFAR3 (0.47) POLBMEN1KMT2AALDH1A1LMNA
SCHEMBL28857096 0.76 MEN1 (0.48) MEN1KMT2AALDH1A1LMNASMN1; SMN2
SCHEMBL5107238 0.75 OPRM1 (0.41) POLBALOX15KDM4EMEN1MAPT
SCHEMBL30932975 0.74 FFAR3 (0.45) POLBMEN1KMT2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7847041-B2 Cobalt-catalyzed asymmetric cyclopropanation of electron-deficient olefins UNIVERSITY OF SOUTH FLORIDA (US) 2010-12-07 US disclosed
US-20100076239-A1 ASYMMETRIC CYCLOPROPANATION OF ELECTRON-DEFICIENT OLEFINS WITH DIAZO REAGENTS UNIVERSITY OF SOUTH FLORIDA (US) 2010-03-25 US disclosed
US-20090069519-A1 COBALT-CATALYZED ASYMMETRIC CYCLOPROPANATION OF ELECTRON-DEFICIENT OLEFINS NATIONAL SCIENCE FOUNDATION 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100076239-A1 ASYMMETRIC CYCLOPROPANATION OF ELECTRON-DEFICIENT OLEFINS WITH DIAZO REAGENTS DUOX2, DUOX1, PPOX POLB 1397/4885ALOX15 120/4885KDM4E 2600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.